Biologic medications are too costly, even after their patents expire. Now there’s an inexpensive alternative.

The cloud division posted an 82% jump as the company’s free cash flow turned negative.

Big Blue’s CEO is expected to face questions from Wall Street about the company’s direction and leadership.

The president’s comments are the latest indication that the fragile ceasefire is on the verge of collapse.

A Florida teen suing social-media platforms over claims their design led to mental health issues dropped his lawsuit against ...

Food-borne illnesses spread despite the FDA’s vastly expanded remit.

The deposed leader, accused by U.S. authorities of narcoterrorism conspiracy, has said he is innocent. His lawyers have ...

The closing of the chokepoints at Hormuz, Bab al-Mandeb and the Black Sea collectively imperils roughly a quarter of the ...

The accord approved by President Trump opens the door to uranium enrichment in the kingdom.

If you can’t articulate an opposing view point, your only hope of a sense of intellectual victory is when your opponent can ...

The EV-maker reported $100 billion in revenue on a trailing 12-month basis for the first time.

The seminal pop-punk album, full of romantic innocence and disarming humor, foreshadowed the rise of new wave.